Risk Profile, Efficacy and Safety of Rituximab in Patients with Relapsed or Refractory Idiopathic Thrombocytopenic Purpura in a Minority Cohort with Long Term Follow up
Autor: | Sreenivasappa, Shylendra B, Catchatourian, R., Yim, Barbara * |
---|---|
Zdroj: | In Blood 16 November 2008 112(11):4546-4546 |
Databáze: | ScienceDirect |
Externí odkaz: |